Detalhe da pesquisa
1.
Sorafenib in patients with locally advanced and metastatic chordomas: a phase II trial of the French Sarcoma Group (GSF/GETO).
Ann Oncol
; 26(10): 2168-73, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26202596
2.
A dose-escalating phase I of imatinib mesylate with fixed dose of metronomic cyclophosphamide in targeted solid tumours.
Br J Cancer
; 109(10): 2574-8, 2013 Nov 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-24149182
3.
French version of the Functional Assessment of Cancer Therapy-Cognitive Function (FACT-Cog) version 3.
Support Care Cancer
; 20(12): 3297-305, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22549504
4.
Megestrol acetate versus metronomic cyclophosphamide in patients having exhausted all effective therapies under standard care.
Br J Cancer
; 102(8): 1207-12, 2010 Apr 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-20354522
5.
Continuation versus discontinuation of first-line chemotherapy in patients with metastatic squamous cell oesophageal cancer: A randomised phase II trial (E-DIS).
Eur J Cancer
; 111: 12-20, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30798084
6.
Prognostic factors for adult sarcomas of head and neck.
Int J Oral Maxillofac Surg
; 37(5): 428-32, 2008 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-18343096
7.
Additional direct medical costs associated with nosocomial infections after head and neck cancer surgery: a hospital-perspective analysis.
Int J Oral Maxillofac Surg
; 37(2): 135-9, 2008 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-18022348